Strides Pharma Science Ltd.

STAR

Market Cap
₹8,107 Cr.
P/E
0.00

Strides Pharma Science Ltd.

Quick View
  • 1d
  • 1m
  • 6m
  • YTD
  • 1y
  • 3y
  • 5y
  • 10y
  • max
locked

Company Timeline

Company Timeline

Subscribe now for more updates
Forensics
Other Income
Other Income is not affecting ratios of the company
Pledge
Promoters have pledged a significant portion of their holding
Revenue Recognition
Chances of aggressive revenue recognition - Operating profit of company is not getting converted to cash and recievables rising faster than sales
Depreciation Effect
Depreciation accounting is not leading to increase in profits
Capex vs ROCE
ROCE of the company has increased over the last three years
Contingent Liabilities
Company does not have significant contingent liabilities
Retail Holding
Retail has been selling the stock which is usually a good time to buy
Share price
Share price has increased over last 10 years due to earnings
ROE
Asset Turnover is responsible for ROE increase over last 10 years
Working Capital
Working Capital of the company seems to be under control
Debt
Company might have issues servicing its debt
Promoter Holding
Promoter has not sold any shares in the last 90 days
Current vs Historic Valuation
Company is trading at a discount to 3 year historic valuations
ROE
Latest
-9.16%
3yr Average
-6.33%
5yr Average
-1.06%
Net Profit Margin
Latest
-5.49%
3yr Average
-4.13%
5yr Average
0.77%
ROCE
Latest
8.2%
3yr Average
5.45%
5yr Average
6.23%
Debt to Equity
Latest
1.25
3yr Average
1.07
5yr Average
1.04
Market Share
50% (as of Mar 19)
Acarbose - Market Share
21% (as of Mar 19)
Acetazolamide - Market Share
11% (as of Mar 19)
Amlodipine - Market Share
18% (as of Mar 19)
Benzonatate - Market Share
52% (as of Mar 19)
Buspirone - Market Share
36% (as of Mar 19)
Calcitriol SGC - Market Share
20% (as of Mar 19)
Efavirenz - Market Share
27% (as of Mar 19)
Ibuprofen Rx - Market Share
23% (as of Mar 19)
Ketoconazole - Market Share
63% (as of Mar 19)
Methoxsalen - Market Share
locked Source
65% (as of Mar 19)
Ranitidine - Market Share
53% (as of Mar 19)
Vanco Caps - Market Share
Show more
Revenue mix

Product Wise Break-Up

locked
Source
|
Latest
|
locked
Historic

Location Wise Break-Up

locked
Source
|
Latest
|
locked
Historic

Customer Segment

locked
Source
|
Latest
|
locked
Historic

Operating Profit Break-Up

locked
Source
|
Latest
|
locked
Historic

Asset Break-Up - Segment Wise

locked
Source
|
Latest
|
locked
Historic

Asset Break-Up

locked
Source
|
Latest
|
locked
Historic
Show more
Operational Metrics

    locked
    Select a Metric
    • Number of ANDA's Filed in USA (.)
      Source
    • Number of ANDA's Approved By USFDA (.)
      Source
    • R&D as a % of Total Sales (%)
      Source
    Peer Comparison
    Brands
    Pediacare
    Suppliers
    Company Filing
    Show Previous Years
    Discussions & Analysis
    Strides Pharma Science Ltd.
    View the discussion on ValuePickr
    Pharmaceutical Sector
    How The Pharma Industry Works - PPFAS
    Phama Industry - Terminologies and Value Chain - Alpha Invesco
    Deep Dive into Pharma Sector - Omkara Capital
    Pharma Compliance In-Depth - Amit Rajan
    Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar
    Nutraceuticals- Industry Overview - Value Educator
    Generic Opportunity for Indian Pharma Companies - Anish Moonka
    timeline